| Date Filed | Type | Description |
| 09/15/2022 |
SC 13D/A
| venBio Global Strategic Fund II L.P. reports a 1.9% stake in Akero Therapeutics, Inc. |
| 06/07/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 05/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/12/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/05/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 05/04/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/29/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/26/2022 |
4
| venBio Global Strategic Fund II L.P. (10% Owner) has filed a Form 4 on Checkmate Pharmaceuticals, Inc.|
Txns:
| Sold 37,430 shares
@ $10.3883, valued at
$388.8k
Sold 27,668 shares
@ $10.3876, valued at
$287.4k
Sold 64,683 shares
@ $10.3823, valued at
$671.6k
|
|
| 04/21/2022 |
4
| venBio Global Strategic Fund II L.P. (10% Owner) has filed a Form 4 on Checkmate Pharmaceuticals, Inc.|
Txns:
| Sold 399,923 shares
@ $10.4151, valued at
$4.2M
Sold 85,611 shares
@ $10.3887, valued at
$889.4k
Sold 62,200 shares
@ $10.3837, valued at
$645.9k
|
|
| 02/14/2022 |
SC 13G/A
| venBio Global Strategic Fund II L.P. reports a 4.7% stake in Harmony Biosciences Holdings, Inc. |
| 05/07/2021 |
SC 13D/A
| venBio Global Strategic Fund II L.P. reports a 6.6% stake in Akero Therapeutics, Inc. |
| 05/07/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 04/29/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/26/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/22/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 02/16/2021 |
SC 13G
| venBio Global Strategic Fund II L.P. reports a 6.2% stake in Harmony Biosciences Holdings, Inc. |
| 10/06/2020 |
SC 13G
| venBio Global Strategic Fund II L.P. reports a 17.1% stake in Checkmate Pharmaceuticals, Inc. |
| 10/01/2020 |
SC 13D
| venBio Global Strategic Fund II L.P. reports a 26.9% stake in ALX ONCOLOGY HOLDINGS INC. |
| 09/09/2020 |
SC 13D/A
| venBio Global Strategic Fund II L.P. reports a 7.7% stake in Akero Therapeutics, Inc. |
| 08/12/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/06/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 07/21/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/16/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 07/06/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/16/2020 |
SC 13D/A
| venBio Global Strategic Fund II L.P. reports a 0% stake in Menlo Therapeutics Inc. |
| 03/06/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/03/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/27/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/12/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/10/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/06/2020 |
4
| venBio Global Strategic Fund II L.P. (10% Owner) has filed a Form 4 on Akero Therapeutics, Inc.|
Txns:
| Sold 53,731 shares
@ $25.6496, valued at
$1.4M
Sold 28,608 shares
@ $25.9909, valued at
$743.5k
|
|
| 01/15/2020 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 01/14/2020 |
4
| venBio Global Strategic Fund II L.P. (10% Owner) has filed a Form 4 on Akero Therapeutics, Inc.|
Txns:
| Sold 494,000 shares
@ $20.23, valued at
$10M
|
|
|